HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/4/H1788    most recent 00066.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Billecke, S. S. Articles by D'Alecy, L. G. Search for Related Content PubMed PubMed Citation Articles by Billecke, S. S. Articles by D'Alecy, L. G.

Contribution of whole blood to the control of plasma asymmetrical dimethylarginine

¹Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor; ²College of Literature, Science, and The Arts and ³College of Engineering, University of Michigan, Ann Arbor, Michigan; ⁴Department of Nutritional Science, Faculty of Health and Welfare Science, Okayama Prefectural University, Kuboki, Soja, Okayama, Japan; ⁵Macromolecular Structure Facility, Michigan State University, East Lansing; ⁶Department of Surgery (Vascular), University of Michigan Medical School, Ann Arbor; and ⁷William Beaumont Hospital, Department of Surgery, Royal Oak, Michigan

Submitted 16 January 2006 ; accepted in final form 11 April 2006

The endogenous nitric oxide (NO) synthase (NOS) inhibitor asymmetrical dimethylarginine (ADMA) is elevated in many patients and may contribute to the initiation and progression of their disease. While some mechanistic pathways have been identified, tissue-specific contributions to ADMA control remain unclear. We sought to determine if whole blood (WB) could participate in ADMA control ex vivo. Anesthetized male Sprague-Dawley rats underwent exsanguinations, and WB preparations were incubated at 37°C for 5 h. ADMA and symmetrical dimethylarginine were analyzed by high-pressure liquid chromatography. Incubation of lysed red blood cell (RBC) supernatant yielded a significant decrease in ADMA that was blocked by 4124W, a synthetic inhibitor of dimethylarginine dimethylaminohydrolase, the only reported enzyme to hydrolyze ADMA. Hydrolysis of ADMA was diminished by addition of physiologically relevant concentrations of zinc (i.e., 20 µM). Conversely, when rat WB or WB supernatant was incubated at 37°C, it liberated quantities of free ADMA (1–2 µM) that in vivo would likely have pathological consequences. Addition of arginine methyltransferase inhibitors to these incubations did not reduce ADMA release, indicating no dominant role for active protein methylation during these incubations. This ADMA liberation was significantly reduced by addition of protease inhibitors, indicating a dependence on peptide bond hydrolysis. Total ADMA (protein incorporated plus free) was determined by acid hydrolysis and found to be 43.18 ± 4.79 µM in WB with 95% of this in RBCs. These ex vivo data demonstrate the potential of blood to control the NO-NOS system by modulating free ADMA.

nitric oxide; protein arginine methyltransferase; symmetrical dimethylarginine; protease

This article has been cited by other articles:

				A. Sonmez, M. I. Yilmaz, M. Saglam, S. Kilic, T. Eyileten, G. Uckaya, K. Caglar, Y. Oguz, A. Vural, M. Yenicesu, et al. The Relationship between Hemoglobin Levels and Endothelial Functions in Diabetes Mellitus Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(1): 45 - 50. [Abstract] [Full Text] [PDF]

				S. S. Billecke, L. G. D'Alecy, R. Platel, S. E. Whitesall, K. A. Jamerson, R. L. Perlman, and C. A. Gadegbeku Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease Nephrol. Dial. Transplant., February 1, 2009; 24(2): 489 - 496. [Abstract] [Full Text] [PDF]

				C. Antoniades, A. S. Antonopoulos, D. Tousoulis, K. Marinou, and C. Stefanadis Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials Eur. Heart J., January 1, 2009; 30(1): 6 - 15. [Abstract] [Full Text] [PDF]

				J. Toth, A. Racz, P. M. Kaminski, M. S. Wolin, Z. Bagi, and A. Koller Asymmetrical Dimethylarginine Inhibits Shear Stress-Induced Nitric Oxide Release and Dilation and Elicits Superoxide-Mediated Increase in Arteriolar Tone Hypertension, March 1, 2007; 49(3): 563 - 568. [Abstract] [Full Text] [PDF]

				J. T. Kielstein, F. Donnerstag, S. Gasper, J. Menne, D. Fliser, A. Kielstein, J. Martens-Lobenhoffer, F. Scalera, S. M. Bode-Boger, and J. Cooke Response to Letter by Tsuda Stroke, December 1, 2006; 37(12): 2871 - 2871. [Full Text] [PDF]